Manipulating the type 1 diabetes disease process, man versus mouse

Diabetes Care

Volumn 25, Issue 7, 2002, Pages 1240-1241

  Palmer, Jerry P ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Puget Sound Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN; GLUTEN;

DISEASE COURSE; EDITORIAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROPHYLAXIS; RISK ASSESSMENT; T LYMPHOCYTE; ANIMAL; DIABETIC DIET; DISEASE MODEL; MOUSE; NONOBESE DIABETIC MOUSE; NOTE; PATHOPHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETIC DIET; DISEASE MODELS, ANIMAL; GLUTEN; HUMANS; MICE; MICE, INBRED NOD; SPECIES SPECIFICITY;

EID: 0036634434     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.7.1240     Document Type: Editorial

References (10)

1. Hummell M, Bonifacio E, Naserke HE, Ziegler AG: Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects. Diabetes Care 25:1111-1116, 2002
2. Atkinson MA, Leiter EH: The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med 5:601-604, 1999
3. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K: Gluten-free diet prevents diabetes in NOD mice. Diabete Metab Res Rev 15:323-327, 1999
4. Diabetes Prevention Trial-Type 1 Study Group: Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002. In press
5. Atkinson MA, Maclaren NK, Luchetta R: Insulitis and insulin dependent diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937, 1990
6. Bowman MA, Campbell L, Darrow BL, Ellis TM, Suresh A, Atkinson MA: Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/seid adoptive transfer model of IDDM. Diabetes 45:205-208, 1996
7. Thivolet CH, Goillot E, Bedossa P, Durand A, Bonnard M, Orgiazzi J: Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 34:314-319, 1991
8. Karounos DG, Bryson JS, Cohen DA: Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J Clin Invest 100:1344-1348, 1997
9. Anastasi E, Dotta F, Tiberti C, Vecci E, Ponte E, Di Mario U: Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose STZ mouse model of diabetes. Autoimmunity 29:249-256, 1999
10. Bottazzo G, Christense A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279-1282, 1974